Nurix Therapeutics (NRIX) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free NRIX Stock Alerts $14.95 +1.01 (+7.25%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Nurix Therapeutics Short Interest DataCurrent Short Volume6,900,000 sharesPrevious Short Volume7,040,000 sharesChange Vs. Previous Month-1.99%Dollar Volume Sold Short$82.94 millionShort Interest Ratio / Days to Cover6.6Last Record DateApril 30, 2024Outstanding Shares49,150,000 sharesPercentage of Shares Shorted14.04%Today's Trading Volume1,488,963 sharesAverage Trading Volume926,515 sharesToday's Volume Vs. Average161% Short Selling Nurix Therapeutics ? Sign up to receive the latest short interest report for Nurix Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNRIX Short Interest Over TimeNRIX Days to Cover Over TimeNRIX Percentage of Float Shorted Over Time Ad Paradigm PressBiden to Drop BOMBSHELL June 13th?Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence. Nurix Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,900,000 shares $82.94 million -2.0%N/A6.6 $12.02 4/15/20247,040,000 shares $108.84 million +1.0%N/A7.2 $15.46 3/31/20246,970,000 shares $102.46 million +8.7%N/A8.7 $14.70 3/15/20246,410,000 shares $83.84 million -6.4%N/A7.9 $13.08 2/29/20246,850,000 shares $84.60 million -5.8%N/A8.5 $12.35 2/15/20247,270,000 shares $71.61 million -0.3%N/A9.2 $9.85 Get the Latest News and Ratings for NRIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,290,000 shares $57.59 million +4.0%16.5%10 $7.90 1/15/20247,010,000 shares $65.68 million +6.4%15.9%9 $9.37 12/31/20236,590,000 shares $68.01 million -25.4%14.9%8.4 $10.32 12/15/20238,830,000 shares $80.18 million +6.0%20.0%12.4 $9.08 11/30/20238,330,000 shares $51.81 million +12.0%18.9%14.7 $6.22 11/15/20237,440,000 shares $47.99 million +4.4%16.9%14.7 $6.45 10/31/20237,130,000 shares $39.86 million +9.0%16.2%15.4 $5.59 10/15/20236,540,000 shares $41.66 million +5.3%14.8%17.2 $6.37 9/30/20236,210,000 shares $48.81 million -1.1%14.2%18.8 $7.86 9/15/20236,280,000 shares $55.64 million +12.5%14.3%20.2 $8.86 8/31/20235,580,000 shares $47.43 million -2.6%12.7%17.4 $8.50 8/15/20235,730,000 shares $51.46 million +2.9%13.1%20.2 $8.98 7/31/20235,570,000 shares $54.08 million +3.5%12.7%19.2 $9.71 7/15/20235,380,000 shares $52.51 million +3.5%12.4%17.3 $9.76 6/30/20235,200,000 shares $51.95 million -1.3%12.1%15.5 $9.99 6/15/20235,270,000 shares $58.55 million +1.4%12.3%15.1 $11.11 5/31/20235,200,000 shares $52.62 million -3.0%12.1%14.6 $10.12 5/15/20235,360,000 shares $58.21 million +3.1%12.7%14.3 $10.86 4/30/20235,200,000 shares $50.08 million +6.6%12.3%13.4 $9.63 4/15/20234,880,000 shares $59.63 million -0.8%11.6%12.8 $12.22 3/31/20234,920,000 shares $43.69 million +1.9%11.7%14.5 $8.88 3/15/20234,830,000 shares $45.06 million +5.9%11.5%14.2 $9.33 2/28/20234,560,000 shares $43.00 million -2.6%10.9%14.1 $9.43 2/15/20234,680,000 shares $48.44 million -0.4%11.1%14.2 $10.35 1/31/20234,700,000 shares $57.76 million -3.1%11.2%13.7 $12.29 1/15/20234,850,000 shares $56.55 million +2.8%11.6%13.5 $11.66 12/30/20224,720,000 shares $51.83 million +0.2%11.2%12.2 $10.98 12/15/20224,710,000 shares $56.10 million -0.4%11.2%11.8 $11.91 11/30/20224,730,000 shares $58.60 million -8.0%11.3%11.6 $12.39 11/15/20225,140,000 shares $72.99 million -8.9%12.2%13 $14.20 10/31/20225,640,000 shares $71.80 million +13.5%13.7%13.7 $12.73 10/15/20224,970,000 shares $54.02 million +0.8%12.6%11.9 $10.87 9/30/20224,930,000 shares $64.24 million +5.1%12.5%11.9 $13.03 9/15/20224,690,000 shares $76.78 million -0.4%11.9%10 $16.37Biden FINISHED On June 13th? (Ad)Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered.Click here now to see his shocking evidence. NRIX Short Interest - Frequently Asked Questions What is Nurix Therapeutics' current short interest? Short interest is the volume of Nurix Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 6,900,000 shares of NRIX short. Learn More on Nurix Therapeutics' current short interest. What is a good short interest ratio for Nurix Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRIX shares currently have a short interest ratio of 7.0. Learn More on Nurix Therapeutics's short interest ratio. Is Nurix Therapeutics' short interest increasing or decreasing? Nurix Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 6,900,000 shares, a drop of 2.0% from the previous total of 7,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Nurix Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nurix Therapeutics: Nuvation Bio Inc. (2.51%), Bicycle Therapeutics plc (6.52%), AnaptysBio, Inc. (18.06%), Mineralys Therapeutics, Inc. (4.46%), Dianthus Therapeutics, Inc. (9.95%), Wave Life Sciences Ltd. (2.27%), Phibro Animal Health Co. (2.76%), CureVac (4.79%), Savara Inc (6.37%), Silence Therapeutics plc (0.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Nurix Therapeutics stock? Short selling NRIX is an investing strategy that aims to generate trading profit from Nurix Therapeutics as its price is falling. NRIX shares are trading up $1.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nurix Therapeutics? A short squeeze for Nurix Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRIX, which in turn drives the price of the stock up even further. How often is Nurix Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRIX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Nuvation Bio Short Interest Bicycle Therapeutics Short Interest AnaptysBio Short Interest Mineralys Therapeutics Short Interest Dianthus Therapeutics Short Interest Wave Life Sciences Short Interest Phibro Animal Health Short Interest CureVac Short Interest Savara Short Interest Silence Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NRIX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe only AI company you should be looking atBehind the MarketsElon to Transform U.S. Economy? Porter & Company